Detalles de la búsqueda
1.
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity.
PLoS Pathog;
17(4): e1009448, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33861802
2.
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial.
Cancer Immunol Immunother;
70(12): 3679-3692, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351436
3.
Characterization of T lymphocytes in severe COVID-19 patients.
J Med Virol;
93(9): 5608-5613, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33913544
4.
Antitumor Activity of Ethanolic Extract from Thymbra Spicata L. aerial Parts: Effects on Cell Viability and Proliferation, Apoptosis Induction, STAT3, and NF-kB Signaling.
Nutr Cancer;
73(7): 1193-1206, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32696667
5.
CD8+CD28-CD127loCD39+ regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?
J Allergy Clin Immunol;
141(6): 2220-2233.e4, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29103633
6.
White matter microstructure alterations correlate with terminally differentiated CD8+ effector T cell depletion in the peripheral blood in mania: Combined DTI and immunological investigation in the different phases of bipolar disorder.
Brain Behav Immun;
73: 192-204, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29723656
7.
Nanoparticles increase the efficacy of cancer chemopreventive agents in cells exposed to cigarette smoke condensate.
Carcinogenesis;
36(3): 368-77, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25653234
8.
HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
Biochim Biophys Acta;
1842(4): 613-22, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24380881
9.
Impaired immune response to Candida albicans in cells from Fanconi anemia patients.
Cytokine;
73(1): 203-7, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25769809
10.
Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system.
HIV Clin Trials;
16(5): 190-6, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26365593
11.
Early CAR- CD4+ T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma.
EJHaem;
5(2): 360-368, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38633118
12.
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.
Cancer Immunol Immunother;
62(6): 1041-52, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23591981
13.
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.
Cancer Immunol Immunother;
62(5): 851-62, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23359087
14.
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice.
J Transl Med;
11: 120, 2013 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23663506
15.
Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells.
FASEB J;
26(2): 788-98, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22038047
16.
Immunological profile of Fanconi anemia: a multicentric retrospective analysis of 61 patients.
Am J Hematol;
88(6): 472-6, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23483621
17.
Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?
Diagnostics (Basel);
13(13)2023 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37443564
18.
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers.
Front Immunol;
14: 1221605, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37680633
19.
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction.
Clin Exp Med;
23(4): 1235-1242, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36372857
20.
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.
J Exp Clin Cancer Res;
42(1): 67, 2023 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36934257